News

A groundbreaking brain imaging study shows why the gold-standard Parkinson’s drug doesn’t work for everyone—and how doctors ...
Scientists at the University of Sydney have uncovered a malfunctioning version of the SOD1 protein that clumps inside brain ...
Catching Parkinson’s disease early is one of the biggest challenges doctors face. Many people with the condition aren’t ...
A breakthrough brain scan shows Parkinson’s drugs can misfire in the brain, helping some patients less than others. The fix?
In a breakthrough study, scientists found that silencing a single overactive enzyme in the brain reversed early damage caused ...
A drug commonly used for Parkinson’s disease, called pramipexole, has shown strong results in helping people with depression that hasn’t improved with standard treatments. This new finding comes from ...
Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key ...
After 45 years of marriage, Mark Geddes and his wife Jill were on the verge of sleeping in separate rooms due to the ...
A cancer immunotherapy may slow Parkinson’s disease by blocking the spread of harmful brain proteins, Johns Hopkins researchers found.
A 12-month clinical trial investigated whether a cough medicine used in Europe called Ambroxol can slow dementia in people with Parkinson’s.
The most notorious was biting the head off a live bat while on stage in Iowa in 1982. He had been catapulting raw meat into ...
Inhibiting an overabundant enzyme saved a key component of a brain signaling pathway that is vital for motor control in a ...